Nordson Corp. (NASDAQ:NDSN) said Tuesday it completed its acquisition of Micromedics Inc., based in St. Paul, Minnesota.
Terms of the deal were not disclosed.
“Micromedics extends Nordson’s expertise in precision dispensing technology and adds to our growing suite of applications in the expanding medical device and life sciences market,” Nordson CEO Michael F. Hilton said in a statement. “The company is an ideal fit with Nordson’s strategy of acquiring high performing market leaders with differentiated technology and significant recurring revenue.”
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Founded in 1982, Micromedics makes a key technology called FibriJet, a single- and dual-syringe surgical device that can deliver biomaterials to a location to control bleeding and heal wounds.
Nordson said Micromedics’ other businesses, including products relating to ear, nose and throat, and surgical instrument protection, would be spun off into a separate company called Summit Medical Inc.
